Japan-based Canon Medical is breaking ground once again with the introduction of Precise IQ Engine (PIQE) DLR and Silver...
In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a ...
Bushu Pharmaceuticals has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to As...
New research from Japan, led by Jichi Medical University, has found several risk factors associated with greater wa...
Terumo Corporation, based in Japan, and the French company Diabeloop, have signed an agreement for a comprehensive strat...
Health2Sync has announced to launch a new version of its mobile app that integrates continuous glucose monitor...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that the Japanese...
Eisai has launched the “Open Network Lab BioHealth Dementia Innovation Challenge (Onlab Bio Dementia)”, a co...
The Global Health Innovative Technology (GHIT) Fund in Japan has announced a total of approximately 750 million yen...
Japan-based Yokogawa Electric Corporation has acquired all shares of Insilico Biotechnology AG, a Germany-based develope...
Venture capitals play a major role in providing financial support to startup companies through strategic investments/men...
Japanese firm Daiichi Sankyo Company has launched DELYTACT® (teserpaturev/G47∆), an oncolytic virus developed by t...
Japanese firm Takeda Pharmaceutical has announced the exercise of its option to acquire UK-based GammaDelta Therape...
A team of scientists at the Center for iPS Cell Research and Application (CiRA), Kyoto University in Japan, has sho...
Daiichi Sankyo has announced the progress of development of DS-5670, an mRNA vaccine in Japan, being evaluated against t...
Tokai University, Toyohashi University of Technology, Chubu University, and DENSO Corporation in Japan have been develop...
Aichi Cancer Center and Fujitsu have announced the development of an artificial intelligence (AI) based solution ab...
Japanese firm Sumitomo Dainippon Pharma and US-based BehaVR, Inc. have signed definitive agreements to develop and ...
